Quality of life in allergic rhinitis

Therapeutic Advances in Respiratory Disease

Volumn 6, Issue 1, 2012, Pages 25-39

  Ozdoganoglu, Tunis ^a   Songu, Murat ^a   Inancli, Hasan Mete ^b  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b NEAR EAST UNIVERSITY   (Turkey)

Author keywords

generic questionnaires; health related quality of life; intermittent allergic rhinitis; perennial allergic rhinitis; persistent allergic rhinitis; quality of life; seasonal allergic rhinitis; specific questionnaires

Indexed keywords

15 DIMENSIONAL HEALTH RELATED QUALITY OF LIFE; ADOLESCENT RHINOCONJUNCTIVITIS QUALITY OF LIFE QUESTIONNAIRE; ALLERGIC RHINITIS; CHILD HEALTH QUESTIONNAIRE; CHILD HEALTH QUESTIONNAIRE PARENT FORM 28; CHILD HEALTH QUESTIONNAIRE PARENT FORM 50; CHILD HEALTH QUESTIONNAIRE PARENT FORM 87; HUMAN; LEARNING DISORDER; MINI RHINOCONJUNCTIVITIS QUALITY OF LIFE QUESTIONNAIRE; NOCTURNAL RHINOCONJUNCTIVITIS QUALITY OF LIFE QUESTIONNAIRE; NOTTINGHAM HEALTH PROFILE; PEDIATRIC RHINOCONJUNCTIVITIS QUALITY OF LIFE QUESTIONNAIRE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; RHINASTHMA QUALITY OF LIFE QUESTIONNAIRE; RHINOCONJUNCTIVITIS QUALITY OF LIFE QUESTIONNAIRE; SATISFACTION PROFILE; SHORT FORM 20; SHORT FORM 36; SICKNESS IMPACT PROFILE; SLEEP DISORDER; SOCIAL LIFE; SOCIOECONOMICS; THE PARENTS OF CHILDREN WITH ENT INFECTION QUALITY OF LIFE QUESTIONNAIRE; VISUAL ANALOG SCALE; WORK DISABILITY;

ATTITUDE TO HEALTH; HUMANS; INFLAMMATION; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; QUALITY OF LIFE; QUESTIONNAIRES; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; WORLD HEALTH;

EID: 84856614335     PISSN: 17534658     EISSN: 17534666     Source Type: Journal    
DOI: 10.1177/1753465811424425     Document Type: Review

References (65)

1. Bachert C. Bousquet J. Canonica G.W. Durham S.R. Klimek L. Mullol J. (2004) Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol 114: 838–844.
2. Baiardini I. Pasquali M. Giardini A. Specchia C. Passalacqua G. Venturi S. (2003) Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. Allergy 58: 289–294.
3. Berdeaux G. Hervie C. Smajda C. Marquis P. (1998) Parental quality of life and recurrent ENT infections in their children: development of a questionnaire: Rhinitis Survey Group. Qual Life Res 7: 501–512.
4. Bergner M. Bobbitt R.A. (1981) The sickness impact profile: development and final revision of a health status measure. Med Care 19: 787–805.
5. Blaiss M.S. (2004) Allergic rhinitis and impairment issues in schoolchildren: a consensus report. Curr Med Res Opin 20: 1937–1952.
6. Blanc P.D. Trupin L. Eisner M. Earnest G. Katz P.P. Israel L. (2001) The work impact of asthma and rhinitis: findings from a population based survey. J Clin Epidemiol 54: 610–618.
7. Bousquet J. Bullinger M. Fayol C. Marquis P. Valentin B. Burtin B. (1994) Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 94: 182–188.
8. Bousquet J. Demarteau N. Mullol J. van den Akker-van Marle M.E. Van Ganse E. Bachert C. (2005) Costs associated with persistent allergic rhinitis are reduced by levocetirizine. Allergy 60: 788–794.
9. Bousquet J. Khaltaev N. Cruz A.A. Denburg J. Fokkens W.J. Togias A. (2008) Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63(Suppl. 86): 8–160.
10. Bousquet J. Neukirch F. Bousquet P.J. Gehano P. Klossek J.M. Le Gal M. (2006) Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol 117: 158–162.
11. Bunnag C. Leurmarnkul W. Jareoncharsri P. Tunsuriyawong P. Assanasen P. Pawankar R. (2005) Quality of life assessment in Thai patients with allergic rhinoconjunctivitis using the SF-36 questionnaire (Thai version). Rhinology 43: 99–103.
12. Canonica G.W. Bousquet J. Van Hammee G. Bachert C. Durham S.R. Klimek L. (2006) Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis. Respir Med 100: 1706–1715.
13. Casale T.B. Blaiss M.S. Gelfand E. Gilmore T. Harvey P.D. Hindmarch I. (2003) First do no harm: managing antihistamine impairment in patients with allergic rhinitis. J Allergy Clin Immunol 111: S835's842.
14. Cingi C. Topuz B. Songu M. Kara C.O. Ural A. Yaz A. (2010) Prevalence of allergic rhinitis among adult population in Turkey. Acta Otolaryngol 130: 600–606.
15. Ciprandi G. Canonica W.G. Grosclaude M. Ostinelli J. Brazzola G.G. Bousquet J. (2002) Effects of budesonide and fluticasone propionate in a placebo-controlled study on symptoms and quality of life in seasonal allergic rhinitis. Allergy 57: 586–591.
16. Cockburn I.M. Bailit H.L. Berndt E.R. Finkelstein S.N. (1999) Loss of work productivity due to illness and medical treatment. J Occup Environ Med 41: 948–953.
17. Crystal-Peters J. Crown W.H. Goetzel R.Z. Schutt D.C. (2000) The cost of productivity losses associated with allergic rhinitis. Am J Manag Care 6: 373–378.
18. EMEA. (2007) Reflection paper on the regulatory guidance for the use of health related Quality of life (HRQOL) measures in the evaluation of medicinal products. Available at: http://www.emea.europa.eu/pdfs/human/ewp/13939104en.pdf.
19. Fireman P. (1997) Treatment of allergic rhinitis: effect on occupation productivity and work force costs. Allergy Asthma Proc 18: 63–67.
20. Gupta R. Sheikh A. Strachan D.P. Anderson H.R. (2004) Burden of allergic disease in the UK: secondary analyses of national databases. Clin Exp Allergy 34: 520–526.
21. Hunt S.M. McKenna S.P. McEwen J. Backett E.M. Williams J. Papp E. (1980) A quantitative approach to perceived health status: a validation study. J Epidemiol Community Health 34: 281–286.
22. Jaeschke R. Singer J. Guyatt G.H. (1989) Measurement of health status: ascertaining the minimal clinically important difference. Controlled Clin Trials 10: 407–415.
23. Juniper E.F. (1998) Impact of upper respiratory allergic diseases on quality of life. J Allergy Clin Immunol 101: 386–391.
24. Juniper E.F. Guyatt G.H. (1991) Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 21: 77–83.
25. Juniper E.F. Guyatt H. Dolovich J. (1994) Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 93: 413–423.
26. Juniper E.F. Rohrbaugh T. Meltzer E.O. (2003) A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis. J Allergy Clin Immunol 111: 484–490.
27. Juniper E.F. Thompson A.K. Ferrie P.J. Roberts J. (1999) Validation of the standardized version of the rhinoconjunctivitis quality of life questionnaire. J Allergy Clin Immunol 104: 364–369.
28. Juniper E.F. Thompson A.K. Ferrie P.J. Roberts J. (2000) Development and validation of the mini rhinoconjunctivitis quality of life questionnaire. Clin Exp Allergy 30: 132–140.
29. Juniper E.F. Thompson A.K. Roberts J.N. (2002b) Can the standard gamble and rating scale be used to measure quality of life in rhinoconjunctivitis? Comparison with the RQLQ and SF-36. Allergy 57: 201–206.
30. Kremer B. (2004) Quality of life scales in allergic rhinitis. Curr Opin Allergy Clin Immunol 4: 171–177.
31. Koscik R.L. Douglas J.A. Zaremba K. Rock M.J. Splaingard M.L. Laxova A. (2005) Quality of life of children with cystic fibrosis. J Pediatr 147(3 Suppl): S64's68.
32. Lavie P. Gertner R. Zomer J. Podoshin L. (1981) Breathing disorders in sleep associated with microarousals in patients with allergic rhinitis. Acta Otolaryngol 92: 529–533.
33. Léger D. Annesi-Maesano I. Carat F. Rugina M. Chanal I. Pribil C. (2006) Allergic rhinitis and its consequences on quality of sleep: an unexplored area. Arch Intern Med 166: 1744–1748.
34. Leong K.P. Chan S.P. Tang C.Y. Yeak S.C. Saurajen A.S. Mok P.K. (1999) Quality of life of patients with perennial allergic rhinitis: preliminary validation of the Rhinoconjunctivitis Quality of Life Questionnaire in Singapore. Asian Pac J Allergy Immunol 17: 163–167.
35. Lierl M.B. (1995) Allergy of the upper respiratory tract, In: Lawlor G.M. Jr. Fischer T.J. Adelman D.C. (eds). Manual of Allergy and Immunology, 3rd, Boston, MA: Little, Brown and Company.
36. Majani G. Biardini I. Giardini A. Senna G.E. Minale P. D–Ulisse S. (2002) Health-related quality of life assessment in young adults with seasonal allergic rhinitis. Allergy 56: 313–317.
37. Marshall P.S. Colon E.A. (1993) Effects of allergy season on mood and cognitive function. Ann Allergy 71: 251–258.
38. McNicholas W.T. Tarlo S. Cole P. Zamel N. Rutherford R. Grin D. (1982) Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis 126: 625–628.
39. Nascimento Silva M. Naspitz C. Sole D. (2001) Evaluation of quality of life in children and teenagers with allergic rhinitis: adaptation and validation of the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ). Allergol Immunopathol (Madr) 29: 111–118.
40. Nishiike S. Ogino S. Irifune M. Arimoto H. Sakaguchi Y. Takeda M. (2004) Measurement of quality of life during different clinical phases of Japanese cedar pollinosis. Auris Nasus Larynx 31: 135–139.
41. Okuda M. (1998) Cost implication of allergic rhinitis. Allergy Immunol 5: 86–91.
42. Okuda M. Ohkubo K. Goto M. Okamoto H. Konno A. Baba K. (2005) Comparative study of two Japanese rhinoconjunctivitis quality-of-life questionnaires. Acta Otolaryngol 125: 736–744.
43. Pariente P.D. LePen C. Los F. Bousquet J. (1997) Quality-of-life outcomes and the use of antihistamines in a French national population-based sample of patients with perennial rhinitis. Pharmacoeconomics 12: 585–595.
44. Passalacqua G. Pasquali M. Ariano R. Lombardi C. Giardini A. Baiardini I. (2006) Randomized double blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites. Allergy 61: 849–854.
45. Raat H. Mohangoo A.D. Grootenhuis M.A. (2006) Pediatric health-related quality of life questionnaires in clinical trials. Curr Opin Allergy Clin Immunol 6: 180–185.
46. Reed S.D. Lee T.A. McCrory D.C. (2004) The economic burden of allergic rhinitis: a critical evaluation of the literature. Pharmacoeconomics 22: 345–361.
47. Revicki D. Hays R.D. Cella D. Sloan J. (2008) Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 61: 102–109.
48. Revicki D.A. Leidy N.K. Brennan-Diemer F. Thompson C. Togias A. (1998) Development and preliminary validation of the multiattribute Rhinitis Symptom Utility Index. Qual Life Res 7: 693–702.
49. Santos C.B. Pratt E.L. Hanks C. McCann J. Craig T.J. (2006) Allergic rhinitis and its effect on sleep, fatigue, and daytime somnolence. Ann Allergy Asthma Immunol 97: 579–586.
50. Schipper H.C.J. Powell V. (1990) Definitions and conceptual issues, In: Spilker B. (ed.). Quality of Life Assessment in Clinical Trials, New York: Raven Press.
51. Schramm B. Ehlken B. Smala A. Quednau K. Berger K. Nowak D. (2003) Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study. Eur Respir J 21: 116–122.
52. Sears M.R. Burrows B. Herbison G.P. Holdaway M.D. Flannery E.M. (1993) Atopy in childhood: II. Relationship to airway responsiveness, hay fever and asthma. Clin Exp Allergy 23: 949–956.
53. Shedden A. (2005) Impact of nasal congestion on quality of life and work productivity in allergic rhinitis: findings from a large online survey. Treat Respir Med 4: 439–446.
54. Sintonen H. (2001) The 15D instrument of health-related quality of life: properties and applications. Ann Med 33: 328–336.
55. Stewart A.L. Hays R.D. Ware J.E. Jr. (1988) The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 26: 724–735.
56. Stuck B.A. Czajkowski J. Hagner A.E. Klimek L. Verse T. Hormann K. (2004) Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial. J Allergy Clin Immunol 113: 663–668.
57. Sundberg R. Toren K. Hoglund D. Aberg N. Brisman J. (2007) Nasal symptoms are associated with school performance in adolescents. J Adolesc Health 40: 581–583.
58. Torrance G.W. (1986) Measurement of health state utilities for economic appraisal. J Health Econ 5: 1–30.
59. Torrance G.W. Feeny D.H. Furlong W.J. Barr R.D. Zhang Y. Wang Q. (1996) Multiattribute utility function for a comprehensive health status classification system: Health Utilities Index Mark 2. Med Care 34: 702–722.
60. Van Cauwenberge P. Juniper E.F. (2000) Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis. Clin Exp Allergy 30: 891–899.
61. Van der Molen T. Sears M.R. de Graaff C.S. Postma D.S. Meyboom-de Jong B. (1998) Quality of life during formoterol treatment: comparison between asthma-specific and generic questionnaires. Canadian and the Dutch formoterol investigators. Eur Respir J 12: 30–34.
62. Vuurman E.F. van-Veggel L.M. Uiterwijk M.M. Leutner D. O–Hanlon J.F. (1993) Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann Allergy 71: 121–126.
63. Walker S. Khan-Wasti S. Fletcher M. Cullinan P. Harris J. Sheikh A. (2007) Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol 120: 381–387.
64. Ware J.E. Sherbourne C.D. (1992) The MOS 36-item short form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30: 473–483.
65. Wyrwich K.W. Bullinger M. Aaronson N. Hays R.D. Patrick D.L. Symonds T. (2005) Estimating clinically significant differences in quality of life outcomes. Qual Life Res 14: 285e95.